Drugs / Begrivac®
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01147081 | Jun → Jul 2010 | influenza | Novartis Vaccines | Completed | No outcome recorded |
| Phase 3 | NCT01032408 | Apr 2010 → Sep 2011 | HIV infectious disease, swine influenza | Chiltern Pesquisa Clinica Ltda | Completed | No outcome recorded |
| Phase 3 | NCT01032395 | Mar 2010 → Oct 2011 | diabetes mellitus, heart disorder, lung disorder, swine influenza | Chiltern Pesquisa Clinica Ltda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Begrivac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01032408 ↗ |
| Known as | Begrivax | “one dose of Begrivax (influenza vaccine)” NCT01147081 ↗ |
| Modality | Vaccine | “inactivated influenza virus vaccine” NCT01032395 ↗ |